[altairprime]

The underlying summary is interesting. In women (whether or not trans), the synthetics increase clotting risk more than the bioidenticals do; and, separately, oral dosing pathways increase clotting risk more than liver-bypassing pathways (patch, gel, etc). I'd like to see more women asked by their surgical team to switch to transdermal patches before surgery rather than asked to stop taking their hormones. Recovery will be worse with preventable hormone imbalances, after all.